万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>神经精神病学

Annals of Neurology(研究方向:临床神经学) (官网投稿)

简介
Annals of Neurology(月刊),创刊于1977年,出版国家为美国。杂志发表广泛兴趣的文章,潜在的高度影响力,了解人类神经系统疾病的机制和治疗。临床和基础神经科学的所有领域,包括新技术,细胞和分子神经生物学,人口科学以及行为,成瘾和精神疾病的研究都是该杂志的兴趣。
本刊为:SCI期刊(2015-2016), SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-8249

3、期刊投稿:

https://mc.manuscriptcentral.com/ana

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017516日星期二

                       

 

Author Guidelines

 

Scope

 

The Annals of Neurology publishes articles of broad interest in neurology, particularly those with high impact in understanding the mechanisms and treatment of diseases of the human nervous system. Although Annals publishes papers using a wide variety of clinical and basic neuroscience methods, we are most interested in those manuscripts that will be of general interest to academic neurologists, including clinical trials and other large-scale studies that inform the practice of medicine. Purely basic studies, without strong clinical or translational potential, are unlikely to have sufficient priority for publication

 

Editorial Office Contact Information:

 

Managing Editor

330 Brookline Avenue

Boston, MA 02215

tel: 617 667 1812

email: aon@bidmc.harvard.edu

 

Manuscript Submission Information

Submission requirements for the Annals of Neurology are in accordance with the ICMJE Uniform Requirements. Please review the following document prior to submission of your manuscript: http://www.icmje.org/urm_full.pdf

 

Submit your manuscripts online at http://mc.manuscriptcentral.com/ana where you and your coauthors may view the status of your manuscript as it progresses through the review process.  Notification of the disposition of each manuscript will be sent by e-mail to the submitting author on the day of decision.

 

Cover letter: At minimum, please include all of the following elements in your cover letter to the editors: 1) type of submission (Research Article, Brief Communication, etc.), the corresponding author complete with a mailing address, telephone and fax numbers, and an e-mail address, 2) a statement certifying that all coauthors have reviewed and approve the contents of the manuscript, that the Annals of Neurology (77:187, 2015) requirements for authorship have been met,, 3) certify that the submission (aside from an abstract) is not under review at any other publication,4) a full statement about all submissions and previous reports that might be regarded as overlapping with the current work (any such work should be referred to specifically and referenced in the new paper), 5) a statement of financial or other relationships that might lead to a perceived conflict of interest

 

Important: If you have any related articles in-press or under review with another journal, please upload these files and designate them as "supplementary material not for review" when prompted. The editorial staff will have access to these files, but reviewers will not

 

Credits and Permissions : Upon acceptance, we will require (1) notice of informed consent; (2) releases to publish photographs of recognizable persons; (3) written permission to use non-original material (including quotations exceeding 100 words or any table / figure) from both author and publisher of the original material; (4) written permission to name any individual acknowledged in the manuscript but not credited as an author. No article will be published without all required permissions.

 

Types of Manuscripts

Annals of Neurology publishes the following types of articles:

 

Research Articles: Research articles are papers reporting the results of original research. Articles are limited to 500 words for the Introduction, 1,500 words for the Discussion, and 4,500 words, 50 references, and eight figures or tables overall. Note that Annals does not permit supplementary material, except for long, bulky tables or videos, hence all of the methods and results must be described in the body of the paper. We ask authors to be parsimonious in wording their Methods and Results sections, referring to other papers, when possible, for methodological details, and to not describe Results in detail that are clearly shown in a table or figure.

 

Brief Communications: Brief Communications should be limited to 1,500 words, with 20 references or fewer, and no more than a total of three tables or illustrations. Annals rarely publishes case reports, unless they definitively identify a new mechanism of disease or treatment.

 

Letters to the Editor and Replies: Letters should be limited to 400 words and may include one table or figure, if essential, and five or fewer references. Only letters addressing previously published articles will be considered. Letters are not an appropriate way to report new research unless it bears directly on the results of a previously published article.

Review Articles: Review articles are broadly based and are meant to cover an important field of neurology in an authoritative way. Reviews are usually invited from individuals who are experts in a field, who are encouraged to contact the Editor-in-Chief.  Reviews should range between 1,500-4,000 words, with up to 80 references.

 

Neurology Grand Rounds: Neurology Grand Rounds are a new feature, meant to recreate the type of presentation that is generally given by an invited speaker in a Grand Rounds series at a major academic medical center. Grand Rounds presentations can be Clinico-Pathology Conferences, or they may present a point of view from a single author or group of authors. The material should focus on the thesis of the presenter, and need be not as broadly based and representative of the field as a typical Review article. Grand Round articles should otherwise follow the same guidelines as Reviews for the length of the article and number of references.

 

NeuroGenesis Articles: The NeuroGenesis series is meant to focus on issues concerning the development of the careers of academic neurologists. Recent contributions have ranged from the decision to enter neurology residency through social networks among previous presidents of the AAN and ANA. NeuroGenesis articles should be limited to 1,500 words and 20 references.

 

Editorials and Commentaries: Commentaries are invited discussions of new papers, and are usually published in the same issue as the target article. Editorials are short opinion pieces concerning issues facing modern academic neurology. Both types of articles are generally invited, and those who seek to write them are encouraged to contact the Editor-in-chief. Editorials and Commentaries should be less than 1,000 words.

 

Organization of the Manuscript:

Coversheet: The first page of every submission should contain all of the following information: (1) title and running head; (2) all authors’ names, degrees and affiliations; (3) corresponding author’s contact information; (4) number of characters in the title and running head; (5) number of words in the Abstract, Introduction, Discussion and the body of the manuscript (not including abstract or references, figure legends, etc.); (6) number of figures, color figures, and tables. (Gathering this information ahead of submission will greatly facilitate the online submission process.)

 

Title: Titles should be short, specific, and clear. Do not use abbreviations in the title.

 

Running head: Please provide a running head title for your submission. Do not exceed 50 characters.

 

Authors: Individuals should be listed individually as authors only if they have contributed to one of the 3 key contributions that justify authorship, listed below in the discussion of "Authorship." Individuals who have participated in large, multi-center studies and who have played an important role in the data collection and analysis of individual patients may be recognized on the Author line of the manuscript as part of a Group related to that study (e.g., Alzheimer Disease Neuroimaging Initiative, Parkinson Study Group, etc.). The composition of the Group should then be acknowledged by a paragraph in the Author Contributions section a table listing the participants and their affiliated institutions. If the study group has more than 15 participants, this information should be gathered in a Supplementary Table, and the Authorship Contribution should direct the reader to the table for information about the Study Group members and affiliations

 

All author names should include first name, middle initial (if provided), last name, and degrees. Author affiliations should be indicated by using superscript numbers. Affiliations are specific to the department level: two authors at one institution but in different departments have separate listings; two authors in the same department will have one affiliation. Statements of equal authorship contribution may be included. At least one person’s name must precede a Group-attributed authorship (e.g. “Robert R. Jones for the Meningitis Study Group”).

 

A paragraph should be included at the end of the manuscript, indicating the contribution of each author to the study.

 

Each named author must file a copy of the Conflicts of Interest form by the International Committee of Medical Journal Editors. A paragraph should be included at the end of the manuscript describing any relevant conflicts of interest for each author. Note that a relevant conflict is one that could bias that author in the conduct of the reported work. Corporate financial relationships that are not relevant to the work should not be listed here, although they should be included in the ICMJE form

 

Abstracts: The second page should contain the Abstract. Abstracts should not contain abbreviations or references. Abstracts for Research Articles must be limited to 250 words and must be structured into subsections for: Objective, Methods, Results, Interpretation. Abstracts for Reviews, Neurology Grand Rounds, Neurogenesis, or Brief Communications, Abstracts are limited to 100 words and should not include subsections

 

Abbreviations: Always spell out abbreviations at first mention, and place the acronym or abbreviation in parentheses immediately after. Abbreviations should be limited to terms that are both long and frequently repeated in the text. Try to avoid using more than six abbreviations in a paper, least the text appear to be written in code.

 

Text for Research Articles and Brief Communications: Sections must appear in the following order: Abstract, Introduction, Methods, Results, Discussion, Acknowledgements, Author Contributions, Conflicts of Interest, and References. This should be followed by Figure Legends, and then any Tables. Acknowledgements should include individuals who have contributed to the work (provided materials, technical assistance, etc.), but are not authors but all such individuals should agree to being included in this way before the manuscript is submitted. The Acknowledgements should also include sources of financial support for the work.

 

The main body of all manuscripts, and all tables included with your submissions must be provided in Microsoft Word .DOC format.

 

Acknowledgements: The authors may BRIEFLY state their thanks to individuals who may have helped. Sources of research funding should also be acknowledged.

 

Author Contributions: Following the Acknowledgements, list the initials of the authors who have contributed to at least one of the key contributions that justify authorship, including 1) conception and design of the study, 2) acquisition and analysis of data or 3) drafting a significant portion of the manuscript or figures (i.e., a substantial contribution beyond copy editing and approval of the final draft, which is expected of all authors). Individuals who contributed data acquisition (including phenotyping and gathering information on patients) but not to the final analysis that is unique to this manuscript (e.g., site investigators in a large clinical trial or contributors to a large patient database) may be included within a Study Group, which may be mentioned collectively on the author line. In that case, the members of the group and their affiliations should be listed in a separate paragraph under Author Contributions. If there are more than 15 authors in the Study Group, the Study Group members and affiliations should be placed in a supplementary file, which should be indicated in the Author Contributions section instead. Individuals who did not fulfill one of these key roles, or who made purely technical contributions, should not be authors, but rather should be acknowledged.

 

Potential Conflicts of Interest: List any real or apparent conflicts of interest of any of the commercial relationships of the authors with the material presented in the paper, and describe briefly what the conflict is (i.e., do not just write "Author AB has been a consultant for XY Corporation," but instead "Author AB has been a consultant for XY Corporation, which owns patent rights to drug Z that was used in this study.")  Do NOT list irrelevant commercial interests of authors, as these just take up space in the journal, and serve to obscure the important relationships. All commercial interests of all named authors should however be included in the ICMJE Conflict of Interest forms filed for each author. If authors feel that they have no potential conflicts of interests relevant to their manuscript then they may simply state "Nothing to report."

 

References: List up to four authors; if more than four, list three and "et al". Arrange in order of citation, and cite all references by number in the text, superscript and without brackets. Please check all references for errors of citation or attribution.Unpublished data, which include articles submitted, but not in press, and personal communications must be given in parentheses in the text, not as references

 

Online Submission: Please review these instructions carefully and take note of further instruction provided at the top of each screen of the seven-stage submission process. Submit your manuscript and all figures, tables, and supplementary materials exactly as instructed to avoid a delay in processing your manuscript.

 

Log in to our submission site and access your Author Center. If you do not already have an account, please create an account for yourself by clicking on the "Create an Account " button. If you have forgotten your password, enter your email address in the field provided on the login screen and click “go” to have your account information emailed to you.

 

To submit a new manuscript, click the indicated link on the main screen.

 

To submit a revision, click “Manuscripts with Decisions” and click on the link located to the right of your manuscript title. Prior to submitting your revision, please review the attachment provided with your most recent decision letter from the Managing Editor.

 

1. Select a Manuscript Type, enter title, running head, and abstract. Enter “none” in the abstract field for letters and other manuscript types that do not require an abstract.  Be sure to respond to all fields marked with a purple “req,” which denotes a required field.  Manuscript submission will fail if any required field is left blank.  Click Next to proceed to step 2.

 

2. Please select the most appropriate “domain” for your manuscript. This is simply used by the Editorial staff to help identify the most appropriate Associate Editor, and has no further bearing on your manuscript. Enter at least one “keyword” associated with the subject or methods of your submission. Click Next to proceed to step 3.

 

3. Enter all authors' names and contact information. Click Next to proceed to step 4.

 

4. Identify potential reviewers and preferred non-reviewers. E-mail addresses are essential for this optional step. You may opt out of recommending preferred or non-preferred reviewers, and there is no guarantee the Editors will follow your recommendation. Click Next to proceed to step 5.

 

5. Paste or attach a Microsoft Word copy of your cover letter. Enter all manuscript metadata (number of pages, number of words in the body of the text, number of tables, etc.) making sure this information matches the information captured on your coversheet. Enter any previously assigned Manuscript IDs, if applicable.Click Next to proceed to step 6.

 

6. Your main document, figures, and supplementary material files may be uploaded in batches of five files. After the first five are uploaded, you will be able to upload five more, and so on.Please be sure to enter any figure legends, and name your figures as they are named in the text when prompted after uploading your figure files. A separate conflict of interest form is required for each author. The form can be obtained here: http://www.icmje.org/coi_disclosure.pdf

 

Do not submit any signed copyright transfer forms to the editorial office during the submission process. Please also remember that offline submissions will only be considered in exceptional circumstances, and must be agreed upon with the Managing Editor in advance of submission.Click “Next” to proceed to the final step.

 

7. The appearance of any red “X” indicates a required field was left blank in the submission process. The manuscript cannot be submitted until all required information is provided. Please carefully review your proofs in both HTML and PDF format. If you notice any problems, please contact the Managing Editor: aon@bidmc.harvard.edu. Do not be alarmed if your figures appear small in the HTML proof. The “Image Spy” link below the figure may be used to zoom in to maximum figure dimensions.Click the blue “Submit” button to submit your manuscript. At the end of a successful submission, a confirmation screen with your manuscript number will appear and you will receive an E-mail confirming that the manuscript has been received by the Journal. If this does not happen, please check your submission in your Author Center and/or contact the Managing Editor.

 

主编辑

 

Clifford B. Saper,医学博士,博士生

 

导师

 

Samia J. KhouryMD

Christine KleinMD

Alvaro Pascual-Leone,医学博士,Scott L. Pomeroy博士,医学博士

Seward RutkoveMD

Martin A. SamuelsMD

Gottfried SchlaugMD

Donald L. Schomer 博士,MD

Christopher A. Walsh博士,博士生导师

 

过去的编辑

 

Fred PlumMD1977-1984

Arthur K. AsburyMD1985-1992

Robert A. FishmanMD1993-1997

Richard T. JohnsonMD1997-2005

Steven L HauserMD2006-2013

 

编辑委员会

 

 

罗伯特·阿尔宾医学博士,安娜堡,密歇根州罗伯特·巴尔霍,加利福尼亚州洛杉矶博士,

Craig Blackstone,博士,贝塞斯达,MD

Rose-Mary Boustany,黎巴嫩贝利特医学博士

David Brooks,纽卡斯尔,英国

Jan Claassen,纽约,纽约

Peter Crino博士,巴尔的摩医学博士Marino

DalakasPhiladelphiaPA

Martin Dichgans,慕尼黑,德国

Dennis W. DicksonMDJacksonvilleFL

Marianne DieterichMD,慕尼黑,德国

David EidelbergMDManhassetNY

Jerome EngelMD,洛杉矶,CA

Eva FeldmanMDPhDAnn ArborMI

Matthew Frosch,博士,波士顿,马萨诸塞州

Steven M. Greenberg博士,波士顿博士, MA

Kenneth HeilmanGainesvilleFL

Argye HillisMDBaltimoreMD

Gregory L. HolmesMDBurlingtonVT

David HoltzmanMDSt. LouisMO

Frances JensenMDPhiladelphiaPA

Jaideep KapurMDCharlottesvilleVA

Dimitri KraincMD,芝加哥,芝加哥,

Randolph S. MarshallMD,纽约州纽约州

迈克尔·奥肯医学博士,盖恩斯维尔,佛罗里达州

Phillip L. Pearl,医学博士,波士顿,马萨诸塞州

罗纳德C. Petersen博士,罗切斯特,MN

Annapurna PoduriMDMPHBostonMA

Michael K. RackeMD,哥伦布,OH

Rajiv RatanWhie PlainsNY

William SeeleyMD,旧金山,CA

David K. Simon,博士,波士顿,MA

David G. StandaertMD,博士,伯明翰,AL

Caroline TannerMD,博士,旧金山,CA

Veronique Van Der Horst博士,博士,波士顿,MA

Eelco WijdicksMD,博士,罗切斯特,MN


投稿问答最小化  关闭